Save time and jump to the most important pieces.
FAIRFAX, Va. and TORONTO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ:AIFF), an Artificial Intelligence ("AI") technology company developing innovative neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders, today announced the closing of its merger transaction with WaveDancer, Inc. ("WaveDancer") (NASDAQ:WAVD). The Company is scheduled to begin trading on The Nasdaq Capital Market ("Nasdaq") under the new ticker symbol ‘AIFF' on August 13, 2024. "Brain health is a critical area of medicine that has been hindered by a lack of technological advancements needed to improve the treatme
FAIRFAX, Va., Aug. 09, 2024 (GLOBE NEWSWIRE) -- WaveDancer, Inc. (NASDAQ:WAVD) ("WaveDancer" or the "Company"), announced today that it intends to effect a reverse stock split of its common stock at a ratio of one (1) post-split share for every three (3) pre-split shares. The reverse stock split will become effective at 12:01 p.m., New York time, on Monday, August 12, 2024, and will begin trading on a split-adjusted basis when the market opens on Tuesday, August 13, 2024. The new CUSIP number for the common stock following the reverse stock split will be 317970101. Additionally, in connection with the Agreement and Plan of Merger, dated as of November 15, 2023, as amended, by and between W
FAIRFAX, Va. and TORONTO, June 20, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company"), a pioneering artificial intelligence ("AI") driven company developing innovative neuroscientific solutions to improve outcomes for patients with mental illnesses and neurological disorders, today announced the expansion of its leadership team with the appointment of Samer Kaba, M.D. as its Chief Medical Officer, as it nears the closing of its planned merger with WaveDancer, Inc. (NASDAQ:WAVD). "We are delighted to welcome Samer to our executive management team," said Jon Olsen, Chief Executive Officer of Firefly. "His proven track record in the neuroscience drug developme
SC 13D/A - WAVEDANCER, INC. (0000803578) (Subject)
SC 13D/A - WAVEDANCER, INC. (0000803578) (Subject)
SC 13D/A - WAVEDANCER, INC. (0000803578) (Subject)
4 - WAVEDANCER, INC. (0000803578) (Issuer)
4 - WAVEDANCER, INC. (0000803578) (Issuer)
4 - WAVEDANCER, INC. (0000803578) (Issuer)
4 - WAVEDANCER, INC. (0000803578) (Issuer)
FAIRFAX, Va. and TORONTO, June 20, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company"), a pioneering artificial intelligence ("AI") driven company developing innovative neuroscientific solutions to improve outcomes for patients with mental illnesses and neurological disorders, today announced the expansion of its leadership team with the appointment of Samer Kaba, M.D. as its Chief Medical Officer, as it nears the closing of its planned merger with WaveDancer, Inc. (NASDAQ:WAVD). "We are delighted to welcome Samer to our executive management team," said Jon Olsen, Chief Executive Officer of Firefly. "His proven track record in the neuroscience drug developme
FAIRFAX, Va. and TORONTO, May 29, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly"), a pioneering artificial intelligence ("AI") company developing innovative neuroscientific solutions to improve outcomes for patients with mental illnesses and neurological disorders, today announced the appointment of Brian M. Posner to its Board of Directors upon closing of its planned merger with WaveDancer, Inc. ("WaveDancer") (NASDAQ:WAVD). Firefly has entered into a definitive agreement and plan of merger (as amended, the "Merger Agreement") with WaveDancer, which has been approved by the stockholders of both companies and both companies are working towards meeting the final closing cond
FAIRFAX, Va. And TORONTO, May 14, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly"), a pioneering artificial intelligence ("AI") company developing innovative neuroscientific solutions to improve outcomes for patients with mental illnesses and neurological disorders, today announced the appointment of David Johnson as its Executive Chairman upon closing of its planned merger with WaveDancer, Inc. ("WaveDancer") (NASDAQ:WAVD). Firefly has entered into a definitive agreement and plan of merger (as amended, the "Merger Agreement") with WaveDancer, which has been approved by the stockholders of both companies and both companies are working towards meeting the final closing condit
8-K - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
NT 10-Q - FIREFLY NEUROSCIENCE, INC. (0000803578) (Filer)
8-K - WAVEDANCER, INC. (0000803578) (Filer)